Literature DB >> 17563472

Anti-inflammatory effects of insulin.

Paresh Dandona1, Ajay Chaudhuri, Priya Mohanty, Husam Ghanim.   

Abstract

PURPOSE OF REVIEW: This review deals with the recent observations on the pro-inflammatory effects of glucose and the anti-inflammatory actions of insulin. Apart from being novel, they are central to our understanding of why hyperglycemia is a prognosticator of bad clinical outcomes including patients with acute coronary syndromes, stroke and in patients in the intensive care unit. RECENT
FINDINGS: The pro-inflammatory effect of glucose as well as that of other macronutrients including fast food meals provides the basis of chronic oxidative stress and inflammation in the obese and their propensity to atherosclerotic disease. The anti-inflammatory action of insulin provides a neutralizing effect to balance macronutrient induced inflammation on the one hand and the possibility of using insulin as an anti-inflammatory drug on the other.
SUMMARY: The actions of macronutrients and insulin described above explain why insulin resistant states like obesity and type 2 diabetes are associated with oxidative stress, inflammation and atherosclerosis. They also suggest that insulin may be antiatherogenic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563472     DOI: 10.1097/MCO.0b013e3281e38774

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  36 in total

1.  Low Plasma Hdl Cholesterol and Elevated C Reactive Protein further Increase Cardiovascular Disease Risk in Latinos with Type 2 Diabetes.

Authors:  Mariana C Calle; Sonia Vega-López; Sofia Segura-Pérez; Jeff S Volek; Rafael Pérez-Escamilla; Maria Luz Fernandez
Journal:  J Diabetes Metab       Date:  2010-11-10

2.  Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.

Authors:  Chase Watters; Jake A Everett; Cecily Haley; Allie Clinton; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

3.  Intraoperative tight glucose control using hyperinsulinemic normoglycemia increases delirium after cardiac surgery.

Authors:  Leif Saager; Andra E Duncan; Jean-Pierre Yared; Brian D Hesler; Jing You; Anupa Deogaonkar; Daniel I Sessler; Andrea Kurz
Journal:  Anesthesiology       Date:  2015-06       Impact factor: 7.892

4.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

5.  β(2)-Adrenoreceptor blockade improves early posttrauma hyperglycemia and pulmonary injury in obese rats.

Authors:  Lusha Xiang; Silu Lu; Peter N Mittwede; John S Clemmer; Graham W Husband; Robert L Hester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-06-13       Impact factor: 4.733

6.  Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma.

Authors:  Rachel C Masters; Angela D Liese; Steven M Haffner; Lynne E Wagenknecht; Anthony J Hanley
Journal:  J Nutr       Date:  2010-01-20       Impact factor: 4.798

Review 7.  Insulin signalling mechanisms for triacylglycerol storage.

Authors:  M P Czech; M Tencerova; D J Pedersen; M Aouadi
Journal:  Diabetologia       Date:  2013-02-27       Impact factor: 10.122

Review 8.  Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.

Authors:  Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

9.  Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice.

Authors:  Chase Watters; Katrina DeLeon; Urvish Trivedi; John A Griswold; Mark Lyte; Ken J Hampel; Matthew J Wargo; Kendra P Rumbaugh
Journal:  Med Microbiol Immunol       Date:  2012-09-25       Impact factor: 3.402

Review 10.  Early insulin treatment in type 2 diabetes: what are the pros?

Authors:  Luigi F Meneghini
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.